EcoDrugPlus

Dihydroorotate Dehydrogenase (Quinone)

Ensembl ID : ENSOKIG00005016614
Gene Symbol: DHODH
3 Cross references
167 Possible Orthologues:

Dihydropyrimidine Dehydrogenase

Ensembl ID : ENSOKIG00005039284
Gene Symbol: DPYD
3 Cross references
166 Possible Orthologues:

Dihydropyrimidine Dehydrogenase [Nadp(+)]

Ensembl ID : ENSOKIG00005023519
Gene Symbol: LOC109875091
3 Cross references
203 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSOKIG00005021534
Gene Symbol: DDR2
3 Cross references
192 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSOKIG00005019403
Gene Symbol: DDR2
3 Cross references
197 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSOKIG00005047831
Gene Symbol: DDR2
3 Cross references
198 Possible Orthologues:

Disintegrin And Metalloproteinase Domain-Containing Protein 17

Ensembl ID : ENSOKIG00005049208
Gene Symbol: LOC109903890
3 Cross references
201 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSOKIG00005041522
Gene Symbol: DRD1
1 Cross references
183 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSOKIG00005041812
Gene Symbol: DRD1
1 Cross references
181 Possible Orthologues:

Dopamine Receptor D2

Ensembl ID : ENSOKIG00005019595
Gene Symbol: DRD2
3 Cross references
203 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSOKIG00005010039
Gene Symbol: DRD3
1 Cross references
195 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSOKIG00005014903
Gene Symbol: DRD3
1 Cross references
195 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).